Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.7B | 6.5B | 6.5B | 6.0B |
Cost of revenue | 4.2B | 4.3B | 4.3B | 4.0B |
Gross profit | 2.4B | 2.3B | 2.2B | 2.0B |
Operating expense | ||||
Research & development | 290.3M | 502.0M | 217.3M | 267.3M |
Selling general and admin | 198.5M | -179.8M | 427.1M | 5.7M |
Other operating expenses | 10.6M | 14.0M | 11.3M | -13.9M |
Operating income | 2.0B | 1.5B | 1.8B | 1.5B |
Non operating interest income | ||||
Income | 41.7M | 28.1M | 38.0M | 17.4M |
Expense | 16.7M | -48.0M | 28.5M | 9.7M |
Other income expense | — | — | — | — |
Pretax income | 2.0B | 1.6B | 1.7B | 1.6B |
Tax provision | 299.3M | 139.6M | 218.5M | 175.0M |
Net income | 1.7B | 1.5B | 1.5B | 1.4B |
Basic EPS | 1.4 | — | — | — |
Diluted EPS | 1.4 | — | — | — |
Basic average shares | 1.1B | — | — | — |
Diluted average shares | 1.1B | — | — | — |
EBITDA | 2.0B | 1.6B | 1.7B | 1.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -107.6M | -81.4M | -70.4M | -30.1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |